Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUDCA in Aging- and Obesity-Induced Vascular Dysfunction
NCT04001647Phase 1Terminated
- Sponsor
- Colorado State University
- Start
- Jun 2019
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tauroursodeoxycholic acid in vascular dysfunction and arterial stiffness, sponsored by Colorado State University. Started Jun 2019; status: terminated.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
vascular dysfunctionarterial stiffness
Beyond the preview
Go deeper on NCT04001647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04001647.